In the News

JAMA News spoke to Pinchas Cohen regarding the possible lifting of FDA restrictions on mitochondria-derived peptides and mentioned his discovery of humanin, MOTS-c and numerous other MDPs. “To offer people the best way to address their health issues, we need to take them further into clinical trials,” Cohen said.

Being Patient quoted Andrei Irimia in an article on normal brain aging vs. dementia. “With a healthy diet and plenty of exercise, the brain ages a bit slower. There are populations out there where, in fact, they’re getting so much exercise that their brains age very slowly,” Irimia said.

AARP Bulletin quoted Carin Kreutzer in an article on how age-related loss of appetite can affect health in older adults and tips to address it. Kreutzer said a decreasing appetite can start a “domino effect” of health issues: “Loss of appetite leads to loss of weight. That leads to loss of muscle mass, which increases your risk of frailty, disease and loss of energy.”

Daily Trojan quoted Paul Nash in an article on the 2026 World Elder Abuse Awareness Day event hosted by the National Center on Elda Abuse.Nash said the issue of ageism is compounded by the fact that people are often unaware that ageism is a serious issue or how to recognize it.

“If I ran down the street and I started saying something sexist or racist, somebody would challenge me. But if I said something ageist, people might just laugh,” Nash said. “How many birthday cards do you see that make racist jokes, as opposed to how many do you see that make ageist jokes?”

Medscape spoke to Pinchas Cohen about the popularity of peptide supplementation despite the lack of rigorous evidence supporting the practice. He noted that he has testified before the FDA multiple times as an expert on other drugs, including human growth hormone, but no one has asked him to present on MOTS-c so far. If they did, he would advise against FDA deregulation at this time and instead appeal for research funding and accelerated clinical trials, he added.